- Home
- MFIC vs BLFS Comparison
MFIC vs BLFS Comparison
Compare MFIC & BLFS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MFIC
- BLFS
- Stock Information
- Founded
- MFIC 2004
- BLFS 1987
- Country
- MFIC United States
- BLFS United States
- Employees
- MFIC N/A
- BLFS N/A
- Industry
- MFIC Finance/Investors Services
- BLFS Medical/Dental Instruments
- Sector
- MFIC Finance
- BLFS Health Care
- Exchange
- MFIC Nasdaq
- BLFS Nasdaq
- Market Cap
- MFIC 1.2B
- BLFS 1.2B
- IPO Year
- MFIC 2004
- BLFS 1989
- Fundamental
- Price
- MFIC $11.74
- BLFS $26.31
- Analyst Decision
- MFIC Buy
- BLFS Strong Buy
- Analyst Count
- MFIC 6
- BLFS 7
- Target Price
- MFIC $13.58
- BLFS $30.86
- AVG Volume (30 Days)
- MFIC 514.1K
- BLFS 356.3K
- Earning Date
- MFIC 11-06-2025
- BLFS 11-11-2025
- Dividend Yield
- MFIC 12.96%
- BLFS N/A
- EPS Growth
- MFIC N/A
- BLFS N/A
- EPS
- MFIC 1.08
- BLFS N/A
- Revenue
- MFIC $324,241,000.00
- BLFS $93,468,000.00
- Revenue This Year
- MFIC $10.33
- BLFS $26.07
- Revenue Next Year
- MFIC N/A
- BLFS $16.86
- P/E Ratio
- MFIC $10.88
- BLFS N/A
- Revenue Growth
- MFIC 16.80
- BLFS 68.16
- 52 Week Low
- MFIC $10.18
- BLFS $19.10
- 52 Week High
- MFIC $14.74
- BLFS $29.55
- Technical
- Relative Strength Index (RSI)
- MFIC 31.69
- BLFS 57.56
- Support Level
- MFIC $11.74
- BLFS $24.33
- Resistance Level
- MFIC $12.02
- BLFS $27.42
- Average True Range (ATR)
- MFIC 0.23
- BLFS 0.89
- MACD
- MFIC -0.04
- BLFS 0.08
- Stochastic Oscillator
- MFIC 13.94
- BLFS 70.51
About MFIC MidCap Financial Investment Corporation
MidCap Financial Investment Corp is an externally managed, publicly traded, closed-end, diversified management investment company. Its investment objective is to generate current income and, to a lesser extent, long-term capital appreciation. It predominantly invests in directly originated and privately negotiated first lien senior secured loans to privately held U.S. middle-market companies, and in other types of securities including, first lien unitranche, second lien senior secured, unsecured, subordinated, and mezzanine loans, and equities in both private and public middle market companies.
About BLFS BioLife Solutions Inc.
BioLife Solutions Inc is a life sciences company that develops, manufactures, and markets bioproduction products and services that are designed to improve quality and de-risk biologic manufacturing, distribution, and transportation in the cell and gene therapy ("CGT") industry. The company provides solutions such as Cell Processing, Cold Chain, and Thawing. The company generates the majority of its revenue from Cell Processing through the biopreservation product "CryoStor". Geographically the company generates the majority of its revenue from the United States.